Vanguard Group’s Tourmaline Bio TRML Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.3M | Buy |
1,207,035
+16,225
| +1% | +$259K | ﹤0.01% | 2572 |
|
|
2025
Q1 | $18.1M | Buy |
1,190,810
+84,685
| +8% | +$1.29M | ﹤0.01% | 2553 |
|
|
2024
Q4 | $22.4M | Buy |
1,106,125
+43,652
| +4% | +$885K | ﹤0.01% | 2536 |
|
|
2024
Q3 | $27.3M | Buy |
1,062,473
+15,351
| +1% | +$395K | ﹤0.01% | 2446 |
|
|
2024
Q2 | $13.5M | Buy |
1,047,122
+132,603
| +14% | +$1.71M | ﹤0.01% | 2754 |
|
|
2024
Q1 | $20.9M | Buy |
914,519
+150,767
| +20% | +$3.45M | ﹤0.01% | 2575 |
|
|
2023
Q4 | $20M | Buy |
763,752
+653,689
| +594% | +$17.1M | ﹤0.01% | 2597 |
|
|
2023
Q3 | $3.09M | Buy |
110,063
+6,276
| +6% | +$176K | ﹤0.01% | 3442 |
|
|
2023
Q2 | $3.16M | Sell |
103,787
-8,708
| -8% | -$265K | ﹤0.01% | 3501 |
|
|
2023
Q1 | $2.11M | Buy |
112,495
+7,314
| +7% | +$138K | ﹤0.01% | 3652 |
|
|
2022
Q4 | $1.07M | Buy |
105,181
+3,481
| +3% | +$35.5K | ﹤0.01% | 3891 |
|
|
2022
Q3 | $2.68M | Sell |
101,700
-113
| -0.1% | -$2.97K | ﹤0.01% | 3621 |
|
|
2022
Q2 | $4.59M | Sell |
101,813
-1,261
| -1% | -$56.9K | ﹤0.01% | 3422 |
|
|
2022
Q1 | $10.1M | Sell |
103,074
-8
| -0% | -$787 | ﹤0.01% | 3144 |
|
|
2021
Q4 | $15.8M | Buy |
103,082
+63,664
| +162% | +$9.73M | ﹤0.01% | 2968 |
|
|
2021
Q3 | $5.35M | Buy |
39,418
+335
| +0.9% | +$45.4K | ﹤0.01% | 3615 |
|
|
2021
Q2 | $5.74M | Buy |
+39,083
| New | +$5.74M | ﹤0.01% | 3523 |
|